Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.

Negre O, Eggimann AV, Beuzard Y, Ribeil JA, Bourget P, Borwornpinyo S, Hongeng S, Hacein-Bey S, Cavazzana M, Leboulch P, Payen E.

Hum Gene Ther. 2016 Feb;27(2):148-65. doi: 10.1089/hum.2016.007.

2.

Donor T lymphocyte infusion following ex vivo depletion of donor anti-host reactivity by a specific anti-interleukin-2 receptor P55 chain immunotoxin.

André-Schmutz I, Le Deist F, Hacein-Bey S, Hamel Y, Vitetta E, Schindler J, Fischer A, Cavazzana-Calvo M.

Transplant Proc. 2002 Nov;34(7):2927-8. No abstract available.

PMID:
12431660
3.

Gene therapy of severe combined immunodeficiencies: from mice to humans.

Hacein-Bey S, Yates F, de Villartay JP, Fischer A, Cavazzana-Calvo M.

Neth J Med. 2002 Aug;60(7):299-301. No abstract available.

PMID:
12430581
4.

Gene therapy of severe combined immunodeficiencies.

Fischer A, Hacein-Bey S, Cavazzana-Calvo M.

Nat Rev Immunol. 2002 Aug;2(8):615-21. Review.

PMID:
12154380
5.

Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein: a novel approach for immunotherapy.

Hamel Y, Blake N, Gabrielsson S, Haigh T, Jooss K, Martinache C, Caillat-Zucman S, Rickinson AB, Hacein-Bey S, Fischer A, Cavazzana-Calvo M.

Hum Gene Ther. 2002 May 1;13(7):855-66.

PMID:
11975851
6.

Gene therapy for human severe combined immunodeficiencies.

Fischer A, Hacein-Bey S, Le Deist F, de Saint Basile G, Cavazzana-Calvo M.

Isr Med Assoc J. 2002 Jan;4(1):51-4. Review. No abstract available.

7.

Gene therapy of severe combined immunodeficiencies.

Fischer A, Hacein-Bey S, Le Deist F, De Saint Basile G, Cavazzana-Calvo M.

Adv Exp Med Biol. 2001;495:199-204. No abstract available.

PMID:
11774567
8.

[T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].

Cavazzana-Calvo M, André-Schmutz I, Hacein-Bey S, Schindler J, Vitetta H, Dupuis S, Quartier P, Chedeville G, Vilmer E, Casanova JL, Buffet R, Caillat-Zucman S, Radford I, Le Deist F, Fischer A.

J Soc Biol. 2001;195(1):65-8. French.

PMID:
11530503
9.

Gene therapy for human severe combined immunodeficiencies.

Fischer A, Hacein-Bey S, Le Deist F, de Saint Basile G, Cavazzana-Calvo M.

Immunity. 2001 Jul;15(1):1-4. Review. No abstract available.

10.

Gene therapy of severe combined immunodeficiencies.

Cavazzana-Calvo M, Hacein-Bey S, Yates F, de Villartay JP, Le Deist F, Fischer A.

J Gene Med. 2001 May-Jun;3(3):201-6. Review.

PMID:
11437325
11.

[Gene therapy of X-linked severe combined immunologic deficiency (SCID-X1)].

Hacein-Bey S, Gross F, Nusbaum P, Yvon E, Fischer A, Cavazzana-Calvo M.

Pathol Biol (Paris). 2001 Feb;49(1):57-66. Review. French.

PMID:
11265225
12.

[Gene therapy for immune deficiencies].

Fischer A, Hacein-Bey S, Le Deist F, de Saint Basile G, de Villartay JP, Cavazzana-Calvo M.

Bull Acad Natl Med. 2000;184(7):1417-28; discussion 1428-30. Review. French.

PMID:
11261248
13.

Gene therapy of severe combined immunodeficiencies.

Fischer A, Hacein-Bey S, Le Deist F, Soudais C, Di Santo JP, de Saint Basile G, Cavazzana-Calvo M.

Immunol Rev. 2000 Dec;178:13-20. Review.

PMID:
11213798
14.

Optimization of retroviral gene transfer protocol to maintain the lymphoid potential of progenitor cells.

Hacein-Bey S, Gross F, Nusbaum P, Hue C, Hamel Y, Fischer A, Cavazzana-Calvo M.

Hum Gene Ther. 2001 Feb 10;12(3):291-301.

PMID:
11177565
15.

[Gene therapy of severe combined immunodeficiencies].

Cavazzana-Calvo M, Hacein-Bey S, de Saint-Basile G, Le Deist F, Fischer A.

Transfus Clin Biol. 2000 Jun;7(3):259-60. Review. French. No abstract available.

PMID:
10919216
16.

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.

Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A.

Science. 2000 Apr 28;288(5466):669-72.

18.

High frequency of a deletion polymorphism of the angiotensin-converting enzyme gene in asthma.

Benessiano J, Crestani B, Mestari F, Klouche W, Neukirch F, Hacein-Bey S, Durand G, Aubier M.

J Allergy Clin Immunol. 1997 Jan;99(1 Pt 1):53-7.

PMID:
9003211
19.

Gene therapy of primary immunodeficiencies.

Fischer A, De Saint Basile G, Disanto JP, Hacein-Bey S, Sharara L, Cavazzana-Calvo M.

Adv Nephrol Necker Hosp. 1997;26:107-20. Review. No abstract available.

PMID:
8922128
20.
21.

[Gene therapy for hereditary immunodeficiencies].

Fischer A, de Saint-Basile G, Disanto JP, Hacein-Bey S, Sharara L, Cavazzana-Calvo M.

C R Seances Soc Biol Fil. 1996;190(1):77-93. Review. French.

PMID:
8881271
22.

[Gene therapy of hereditary immunologic deficiencies].

Fischer A, de Saint-Basile G, Disanto JP, Hacein-Bey S, Sharara L, Cavazzana-Calvo M.

Arch Pediatr. 1996;3 Suppl 1:69s-76s. Review. French. No abstract available.

PMID:
8795972
23.

Effects of vasopressin on receptor-mediated endocytosis of asialoglycoprotein by hepatocytes from normal and diabetic rats.

Gil-Falgon S, Lamaze C, Hacein-Bey S, Feger J.

Exp Cell Res. 1992 Apr;199(2):223-8.

PMID:
1531957

Supplemental Content

Loading ...
Support Center